Psychedelics: the future of mental health treatments?
Herald Sun, 05 March, 2023
Australia has become the first country in the world to legalise the therapeutic use of MDMA and psilocybin.
"Historic Supply Agreement Signed"
Globe News Wire, 01 March, 2023
Mind Medicine Australia enters into historic supply agreement with Canadian end-to-end GMP manufacturer, Optimi Health. Read the full media release from Optimi Health.
Psilocybin promotor's response
ABC, 27 February, 2023
Mind Medicine Australia share their thoughts on the recent approval of psychedelic compounds for treatment-resistant depression and PTSD.
The Recent TGA Rescheduling of Psilocybin and MDMA Will Help Solve Our Accelerating Mental Health Epidemic
The Social Blueprint, 17 February, 2023
Enter Mind Medicine Australia, a registered charity and Australia’s leading not-for-profit organization working on the use of medicinal psilocybin and MDMA-assisted therapies to treat a range of mental illnesses and expand the treatment options available to medical practitioners and their patients in clinical environments.
The changing legal landscape of psychedelics in Australia
Lawyers Weekly, 16 February, 2023
Peter Hunt AM has been a leading advocate for change to the legal classification of psychedelic medicines in Australia, with the hope that it will revolutionise mental healthcare and outcomes for those across Australia.
On this episode of The Lawyers Weekly Show, host Jess Feyder speaks with Mr Hunt, co-founder of the organisation Mind Medicine Australia, about psychedelic medicines and the changing legalities in Australia.
MDMA and psilocybin treatments to be offered in the Hunter for PTSD and depression
Newcastle Herald, 17 February, 2023
MDMA and psilocybin treatments to be offered in the Hunter for PTSD and depression through psychiatrist Dr Stuart Saker, as Vietnam veteran and PTSD sufferer Roger Priest shares his story.
Australia Becomes First Nation To Allow Medical Use of Magic Mushrooms and MDMA
Longevity Live, 15 February, 2023
In recent years, the opinion of psychedelic drugs has shifted, especially with growing research suggesting their potential as health-improving medicines. Now, in a groundbreaking decision, Australia recently announced that as of July 1st, it would legalize the use of psilocybin and MDMA – for health conditions of course.
Magic Cure Or An Expensive Trip? Psychedelics Explained
The Quicky - Mamamia Podcasts, 09 February, 2023
In today’s episode of The Quicky, Tania de Jong and Vanessa Bortolin sit down to discuss psychedelic treatment for mental illness, the recently announced TGA decision, and Vanessa’s tragic story.
From Magic Mushrooms to Meds
Australian Financial Review, 12 February, 2023
The TGA’s approval of the psychedelics MDMA and psilocybin as medicines has generated anxiety about a lack of regulation, but also optimism that they might succeed where other treatments fail.
What went right this week: psychedelics for mental health, plus more
Positive News, 09 February, 2023
Australia has become the first country to recognise psychedelics as medicines for treating depression and post-traumatic stress disorder (PTSD).
The landmark decision by Australia’s Therapeutic Goods Administration means that MDMA (commonly known as ecstasy) and psilocybin – the active compound in ‘magic’ mushrooms – will finally be available on prescription after decades of demonisation.
Australia just legalised MDMA to treat mental health. Could Europe do the same?
Euro News, 10 February, 2023
This week, Australia has announced it will officially recognise psychedelic drugs MDMA and psilocybin as medical treatments for conditions including PTSD, depression, alcoholism and eating disorders.
The news has come as a bit of a surprise; Australia’s Therapeutic Goods Administration (TGA) overruled the use of psychedelic drugs as recently as December 2021.
TGA approves magic mushrooms to treat mental health conditions
6PR Perth, 06 February, 2023
The Therapeutic Goods Administration (TGA) has approved the use of psychedelic drugs to treat certain mental health conditions. Drugs such as magic mushrooms and MDMA will be allowed to be prescribed for certain conditions such as depression and PTSD.
Australia will be one of the first countries to recognise psychedelic drugs as medicine. Health Insurance Fund CEO Justin James told Oliver Peterson at Perth Live it is a welcome announcement.
Magic mushrooms and MDMA will soon be legalised for treatment of mental health conditions in Australia
News.com.au, 06 February, 2023
The TGA has legalised psilocybin and MDMA for treatment of PTSD and depression, making Australia the first country in the world to recognise psychedelics as medicines.
In a landmark announcement from the Therapeutic Goods Association (TGA), medicines containing psilocybin and MDMA will soon be legalised to prescribe for treatment of some mental health conditions in Australia.
Australia Becomes The First Country To Approve MDMA And Psilocybin For Medical Use
EDM Tunes, 08 February, 2023
Hooray for Australia! Today, Australia became the first country to approve the use of two psychedelics for medical purposes. The psychedelics in question are MDMA, better known by its street name ecstasy, and psilocybin found mainly in mushrooms. This marks a historical move, as Australia becomes the first country to approve both substances for medical use. The reactions to the legalization of these psychedelic substances have been mixed.
Psychedelics May Be Part of U.S. Medicine Sooner Than You Think
Time, 08 February, 2023
It came as a surprise to many when, on Feb. 3, Australian regulators announced that medicines containing the psychedelic substances MDMA and psilocybin can soon be used there to treat post-traumatic stress disorder (PTSD) and treatment-resistant depression, respectively. That decision makes Australia the first country in the world to formally recognize the therapeutic use of psychedelics.
Other countries, including the U.S., may be headed toward a similar outcome, some experts say.
TGA Approves Psilocybin, MDMA for Mental Health Treatment
Man of Many, 08 February, 2023
To the surprise of many in the healthcare community, mushrooms and ecstasy will be available by prescription from authorised psychiatrists to treat depression and post-traumatic stress disorder (PTSD) in controlled conditions from 1 July. Much like the approval of Medicinal Cannabis back in 2016, Australia’s medical regulator shock decision has opened the door to alternative mental health treatments following the promising results from international studies investigating the role MDMA and Psilocybin can play in treating mental health conditions.
VIDEO - Gravitas: Australia approves medical use of MDMA
WION, 08 February, 2023
Australia has become the first nation to approve the legal use of MDMA & Psilocybin. These ‘psychedelic therapies’ can now be availed by the people. Molly Gambhir reports.
Prescribing MDMA and psilocybin: who will get the drugs and how will they help?
The Guardian, 07 February, 2023
Explainer: doctors say the drugs can help patients work through psychotherapy for PTSD – a condition that will affect one in five people in their lifetimes.
Australia is the first country to allow MDMA and magic mushrooms for medical use
Time Out, 06 February, 2023
The move has been praised by those in the health and medical industry
Biotechs scramble as Australia leads world in psychedelics
Financial Review, 06 February, 2023
Biotechs backed by billionaires Andrew Forrest and Gina Rinehart are racing to get psychedelic therapies ready for market after Australia became only the second country to approve their use to treat depression and PTSD.
TGA approval for MDMA and psilocybin 'huge relief' for air force veteran with severe depression
ABC News, 06 February, 2023
Air Force Veteran and MMA Chapter Leader Michael Raymond shares his reaction to the rescheduling of MDMA & psilocybin with ABC News.
TGA’s approval of MDMA and Psilocybin for medical use is a result of ‘renewed interest’
Sky News, 06 February, 2023
Neuromedicines Discovery Centre Deputy Director Professor Chris Langmead comments on the TGA’s rescheduling of MDMA and psilocybin.
Australia The First Nation To Approve The Legal Use Of MDMA And Psilocybin
Forbes, 06 February, 2023
Following decades hidden in the shadows, psychedelic drugs are at last being recognized by governments around the world as potentially life-saving medicines. Now a recent landmark decision by the Australian Therapeutic Goods Administration (TGA) will soon put that idea into legal practice and make it possible for psychiatrists to prescribe psilocybin and MDMA as early as July of this year.
VIDEO: Hope For PTSD & Depression Sufferers With MDMA & Psilocybin Treatment
The Project, 05 February, 2023
Australia has just become the first country to legalise Magic Mushrooms and MDMA as medicines. It is hoped they’ll soon provide a glimmer of hope for the millions of Aussies living with depression and PTSD. Air Force veteran Michael Raymond and spokesperson for Mind Medicine Australia joins us.
VIDEO: Regulator approves two psychedelics for depression & PTSD
ABC News, 04 February, 2023
Although advocates have welcomed the surprise decision, some experts fear the move is premature. They are urging caution for the use of therapies they say are promising, but ultimately unproven.
TGA approved psychedelics for mental health may stop ‘backyard prescribing’
News.com.au, 04 February, 2023
Video coverage discussing the TGA’s decision to reschedule psilocybin and MDMA for medical use, featuring Brain & Mind Centre Co-Director Professor Ian Hickie.
VIDEO: TGA approves use of psychedelics to treat mental health
ABC News, 04 February, 2023
ABC TV News’ coverage of the TGA’s decision to reschedule psilocybin and MDMA for medical use.
Australian approval of MDMA and psilocybin a ‘baby step in the right direction’, medical experts say
The Guardian, 04 February, 2023
Psychiatrists have cautiously welcomed the ability to prescribe MDMA and psilocybin, saying it’s a “baby step in the right direction”.
The Therapeutic Goods Administration announced on Friday that, from July, approved psychiatrists would be able to prescribe MDMA (ecstasy) for post-traumatic stress disorder and psilocybin (found in magic mushrooms) for treatment-resistant depression.
TGA approves MDMA and psilocybin for therapeutic use in ‘controlled medical settings’
The Australian, 03 February, 2023
Australia will allow psychedelic drugs to be used in the treatment of specific health conditions from July 1.
On Friday the Therapeutic Goods Administration (TGA) announced changes to the classification of psilocybin, a naturally occurring psychedelic compound, and MDMA, allowing the prescription of medicines containing these compounds.
TGA psychedelics decision met with relief, cautious optimism and 'serious reservations'
ABC News, 05 February, 2023
Advocates have welcomed a surprise decision from Australia’s drug regulator to approve two psychedelic drugs for mental health treatment, but some clinicians are concerned the decision may be premature.
Australia becomes first country to recognise psychedelics as medicines
Sydney Morning Herald, 03 February, 2023
Australia has become the first country to recognise psychedelics as medicines, after the Therapeutic Goods Administration took researchers by surprise and approved the psychedelic substances in magic mushrooms and MDMA for use by people with certain mental health conditions.
TGA approves MDMA, psilocybin for mental health treatment
Business News Australia, 03 February, 2023
Australia’s therapeutics regulator has announced today that psychiatrists will soon be able to prescribe psychedelic drugs MDMA and psilocybin to treat patients suffering from post-traumatic stress disorder (PTSD) and depression.
MDMA and magic mushrooms to be prescribed by psychiatrists
Cairns Post, 04 February, 2023
MDMA and magic mushrooms can now be prescribed by psychiatrists to help treat some mental conditions.
The Therapeutic Goods Administration (TGA) announced on Friday the drugs would be removed from the Poisons Standard prohibited substances to the controlled medicines classification.
Huge News: MDMA & Magic Mushrooms Will Soon Be Legal To Treat PTSD & Depression In Australia
Pedestrian, 04 February, 2023
In a world first, the Therapeutic Goods Administration (TGA) has signed off on the use of MDMA and Psilocybin (the chemical compound present in magic mushrooms) for medicinal purposes in Australia. We simply love to see it.
Australia approves MDMA and Psilocybin as Medicines
MM News, 04 February, 2023
Australia has announced it will officially recognize MDMA for the treatment of post-traumatic stress disorder (PTSD), and psilocybin, the active ingredient in magic mushrooms, for treatment-resistant depression.
TGA approves psilocybin, MDMA for treating depression and PTSD
Prensa Latina News, 04 February, 2023
ustralia´s medical regulator has passed the use of psychedelics to treat some mental health conditions, making the country one of the first in the world to officially recognize MDMA (ecstasy) and psilocybin as medicines.
Australia's Rescheduling of MDMA & Psilocybin Could Change...Everything?
The Trip Report, 04 February, 2023
Welcome to this week’s Trip Report by Beckley Waves.
The original title of today’s post was “Bridging the Gap” since I sense that the psychedelic field has entered the “slope of creating psychedelic infrastructure” that will bridge the gap between the increasing demand (that is currently turning to the underground) and safely, effectively and legally meeting that demand.
But then Australia went and legalized MDMA and Psilocybin…
MDMA and Psilocybin Are Approved as Medicines for the First Time
Wired, 03 February, 2023
In a world-first, Australia has announced it will officially recognize MDMA and psilocybin as medicines.
MDMA and psilocybin approved by TGA for medical use in Australia
7 News, 03 February, 2023
People suffering serious mental health conditions will be able to be prescribed psychedelic drugs MDMA and psilocybin within six months.
The Therapeutic Good Administration made the decision following calls to reclassify the substances, but only specifically authorised psychiatrists will be able to prescribe them.
MDMA and psilocybin approved to treat some mental health conditions from July 1
9 News, 03 February, 2023
MDMA and psilocybin have been approved to treat some mental health conditions by Australia’s health regulatory body.
The Therapeutic Goods Administration (TGA) has approved the prescription of MDMA for treating post-traumatic stress disorder and psilocybin (the active ingredient in magic mushrooms) for treatment-resistant depression from July 1.
MDMA and magic mushrooms approved for medical use in Australia after TGA ruling
Sky News, 03 February, 2023
MDMA and psilocybin have been approved for use by psychiatrists to treat people suffering from serious mental health conditions.
The Therapeutic Goods Administration (TGA) on Friday approved the prescription of MDMA for post-traumatic stress disorder and psilocybin for treatment-resistant depression.
TGA approves psilocybin and MDMA for use in treating depression and PTSD
ABC News, 03 February, 2023
Australia’s medical regulator has approved the use of psychedelics to treat some mental health conditions, making the country one of the first in the world to “officially recognise MDMA and psilocybin as medicines”.
Australia to allow prescription of MDMA and psilocybin for treatment-resistant mental illnesses
The Guardian, 03 February, 2023
After decades of “demonisation”, psychiatrists will be able to prescribe MDMA and psilocybin in Australia from July this year.
The Therapeutic Goods Administration made the surprise announcement on Friday afternoon.
Australia is legalising mushrooms and MDMA for medical use
Dazed, 03 February, 2023
Australia is to become the first country to recognise MDMA and magic mushrooms as medicine. The news was announced this afternoon (February 3), with both drugs set to be prescribed in cases of treatment-resistant mental illnesses.
Australia approves medical magic mushrooms and ecstasy
Deutsche Welle, 03 February, 2023
Australian authorities have announced that they will allow MDMA and psilocybin — the respective active ingredients of ecstasy pills and magic mushrooms — for medical treatments.
Australia to legalise use of MDMA and magic mushrooms for treating depression
WION, 03 February, 2023
The drug watchdog of Australia on Friday announced that the authorities will be soon legalising psychedelic substances MDMA and psilocybin, which are commonly known as magic mushrooms and ecstasy, for treating patients who are suffering from depression and post-traumatic stress.
Australia to Legalize MDMA And Magic Mushrooms for Medical Use
Voice of America, 03 February, 2023
Australia’s drugs watchdog on Friday announced that psychedelic substances MDMA and psilocybin — more commonly known as ecstasy and magic mushrooms — will soon be used in the treatment of depression and post-traumatic stress.
The banker and the soprano who became psychedelic pioneers
The Australian: Business Review, 16 December, 2022
Feature Article from The Australian: Business Review.
Famed investment banker Peter Hunt and trail-blazing soprano Tania de Jong’s controversial mission to legalise psychedelics has both brought them closer and been their biggest challenge.
Read the PDF here.
Interview with Professor David Nutt
ABC 774 Melbourne with Ali Moore, 01 December, 2022
Professor David Nutt is interviewed on ABC 774 Melbourne with Ali Moore.
Professor David Nutt in Australia to Advocate for Psychedelic-Assisted Therapies
The Canberra Times, 28 November, 2022
The Canberra Times features Vanessa’s story, along with the presence of Professor David Nutt (Head of Neuropsychopharmacology at Imperial College London) touring Australia to present keynotes on Psychedelic-assisted therapy: History, Neuroscience and Myths, were both advocating in Canberra this week for the Therapeutic Goods Administration to reschedule MDMA and psilocybin.
Experts call for Medicinal Psychedelics to be Approved as Mental Health Treatment
7 News - Sunrise, 25 November, 2022
Professor David Nutt was interviewed on Sunrise, explaining how MDMA can help people with PTSD and the evidence behind the therapies as to why it should be approved in Australia.
The push for using psychedelics in trauma treatment | ABC News
ABC News Australia, 25 November, 2022
Professor David Nutt and Vanessa were featured on ABC News Australia, explaining how psychedelic-assisted therapy can help a range of people with mental illnesses, the evidence behind the therapies and why it should be approved in Australia. The segment also briefly addresses the Therapeutic Goods Administration’s decision on psychedelic-assisted therapies to be implemented in the Australia Mental Health system.
Interview with Professor David Nutt on the Neil Mitchell Program
3AW Mornings, 24 November, 2022
Professor David Nutt, head of Neuropsychopharmacology at Imperial College London, was interviewed on the Neil Mitchell program, and discussed how psychedelic-assisted therapies could help people with treatment-resistant PTSD and depression, the effects and differences between Psilocybin and MDMA, uncovering myths on addiction and government regulation.
Interview with Professor David Nutt on Drive with Richard Glover
ABC Sydney, 24 November, 2022
Professor David Nutt, head of Neuropsychopharmacology at Imperial College London, was interviewed on the Drive with Richard Glover explaining the neuroscience and processes behind how psychedelic-assisted therapy (psilocybin, MDMA and cannabis) can be used to treat treatment-resistant patients suffering from mental illnesses. Professor David Nutt also uncovers the myths regarding psychedelics, the political influence on these substances and how the rescheduling of Psilocybin and MDMA can help treat severely treatment-resistant patients with depression and PTSD.
In 2018, Vanessa's husband was diagnosed with depression. He asked her to help him take his own life.
Mamamia, 24 November, 2022
Vanessa delivers a letter to the Prime Minister Anthony Albanese, telling the story of her husband’s suicide and requesting his assistance in creating a new treatment pathway for people with treatment resistant depression by allowing limited access to psychedelic-assisted therapy.
Approach to Psychedelics 'Ignorant' in Mental Health Crisis
The Australian, 24 November, 2022
Professor David Nutt (UK), Head of Neuropsychopharmacology at Imperial College London met with the TGA on Monday 22nd of November.
Interview with Professor David Nutt (UK)
ABC Sydney, 21 November, 2022
Professor David Nutt (UK), Head of Neuropsychopharmacology at Imperial College London, was recently a guest on ABC Sydney. Listen to the full interview beginning from 00:35:40.
Q&A with Professor David Nutt
The Weekend Australian Magazine, 13 November, 2022
Q&A with Professor David Nutt, in preparation for his Australian tour, opening on November 17.
Woman pens devastating letter to PM advocating for psychedelic substance approval for depression treatment
News.com.au, 13 November, 2022
A heartbroken woman has accused the Albanese Government of “cruelty” after her husband took his own life.
Professor David Nutt live on ABC North Coast Breakfast
ABC North Coast, Breakfast, 08 November, 2022
Professor David Nutt is interviewed on ABC North Coast Breakfast, speaking of the remarkable promise of psychdelic-assisted therapies and promoting his upcoming Australian lecture tour. Interview begins 46:23.
The Psychedelic Mental Health Revolution
The Sachin and Adam Show, 27 September, 2022
The Sachin and Adam Show explore the use of psychedelics for mental health. There are few things more important than mental health and this week they dived deep into how Psychedelic-Assisted Therapy can be the next frontier in treating mental health. The podcast explored Peter’s motivations, the history of psychedelics, the current state of Australia’s mental health system and Mind Medicine Australia.
Move To Ban Psychedelic Medicine Branded Inflexible and a Backward Step
The Age, 08 September, 2022
Victorian health bureaucrats want to ban the use of psychedelic-assisted treatments retrospectively for patients suffering from serious treatment-resistant mental illness, an approach the federal regulator (TGA) has slapped down as inflexible, and one advocate argues is reminiscent of the “war on drugs”. Given what our Premier describes as a “broken mental health system” in Victoria and an increasing mental illness epidemic, this is a cruel and backward step that could deny people the help they need and deserve.
The Truth About Psychedelics
The Deep, 30 August, 2022
Executive Director of Mind Medicine Australia, Tania de Jong AM, was recently a guest on The Deep podcast. In the episode on psychedelics, they discuss the potential of psilocybin-assisted psychotherapy in treating depression, PTSD and other mental health conditions.
The Way of The Psychonaut
Byron Magazine, 15 August, 2022
Following the success of last year’s Fantastic Fungi screening, Mind Medicine Australia is thrilled to announce an exclusive screening of The Way of the Psychonaut: Stanislav Grof’s Journey of Consciousness, at Byron Bay Theatre on Thursday 25 August at 6:30pm followed by a Q&A Panel, hosted by Mind Medicine Australia’s Byron Bay Chapter.
Tania de Jong AM speaks about the importance of ethical reporting
ABC North Coast Breakfast with Joanne Shoebridge, 27 July, 2022
Hear Tania de Jong AM speak about the Four Corners documentary on ABC North Coast and the importance of ethical reporting and fact checking.
The segment runs from: 2:04:25 – 2:15:54.
Healing with Psilocybin
Fierce Truths Magazine, 22 July, 2022
Tania de Jong AM speaks about the potential of psychedelic-assisted psychotherapies and the work we do at Mind Medicine Australia
Michael Pollan changed his own mind with psychedelics. Now he’s changing others
The Sydney Morning Herald, 18 July, 2022
The article discusses Michael Pollan’s book “How to Change Your Mind” and the current state of psychedelics.
Tony Shields Interview on ABC Radio Canberra
ABC Canberra Mornings, 04 July, 2022
Tony Shields discusses the potential in psychedelic-assisted psychotherapies. The interview begins at 1:03:07.
2GB Healthy Living Podcast with Tania de Jong AM
2GB Healthy Living Podcast with Dr Ross Walker, 26 June, 2022
In a recent episode of the Healthy Living Podcast, Mind Medicine Australia’s Executive Director, Tania de Jong AM, speaks about the potential in psychedelic-assisted psychotherapies.
The interview starts at 1:03:56.
NFTs Are Getting Psychedelic. Is It Worth the Trip?
Lucid News, 13 June, 2022
NFTs Are Getting Psychedelic. Is It Worth the Trip?
Let doctors use MDMA to treat veterans with PTSD and depression, former ADF boss says
The Guardian, 04 June, 2022
Chris Barrie says he hopes common sense will prevail and the TGA will allow drug to be more readily used to treat patients.
Ex-ADF chief calls for psychedelic treatment in the ACT
City News, 03 June, 2022
The ex-chief of the Australian Defence Force has urged the ACT government to allow medical use of psychedelic-assisted therapy in treating veterans and individuals suffering from mental illness.
Psychedelic drugs aren’t for parties anymore
The Australian, 03 June, 2022
The case for psychedelic therapy to treat depression, anxiety and PTSD a no-brainer. Don’t cloud it with the debate to decriminalise recreational mood-altering drugs.
ACT government considers Mind Medicine Australia reform to allow psychedelics
Canberra Times, 29 May, 2022
The ACT government is considering legislation changes to allow MDMA-assisted therapy to treat post-traumatic stress disorder and psilocybin to treat depression.
Michael finds a way to see ‘beautiful things’ again
CBR Business News, 24 May, 2022
Royal Australian Air Force officer of 16 years, Michael Raymond, speaks about psychedelic-assisted therapies.
Insight Ep 13: Illicit Medicine
SBS, 09 May, 2022
Is the war on drugs holding us back from developing new therapies, and denying people viable treatments?
Biotechs want to unlock the psychedelics market, but it isn’t simple
The Sydney Morning Herald, 08 May, 2022
Australian biotechs are high on optimism about the multi-billion dollar potential of psychedelic treatments for mental health, but regulators still have question marks.
The Year that Made Me: Tania De Jong, 2017
ABC Sunday Extra, 24 April, 2022
MMA’s Executive Director, Tania de Jong AM, talks about undergoing psychedelic therapy and the focus it gave her. She is currently in rehearsal for the premiere season of the musical, Driftwood, which is based on the memoir of her mother, Eva, and the story of her grandparents, who escaped the Holocaust.
Could psychedelic mushrooms be the answer to treating depression?
6PR Mornings with Liam Bartlett, 13 April, 2022
Listen to our Executive Director, Tania de Jong AM, discuss the potential in psychedelic medicines on 6PR Mornings with Liam Bartlett.
PharmAla Biotech to supply Mind Medicine Australia with GMP MDMA for Clinical Trial
News Wire, 08 April, 2022
PharmAla’s GMP MDMA will accelerate trial work funded by Australia’s premier Psychedelics charity.
Professor David Nutt (UK) Interview on FM104
FM104, 05 April, 2022
Mind Medicine Australia Ambassador Professor David Nutt (UK) discusses the current state of psychedelics including the progress with Mind Medicine Australia.